These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3044982)

  • 21. Stimulation of human neutrophils, monocytes, and platelets by modified C-reactive protein (CRP) expressing a neoantigenic specificity.
    Potempa LA; Zeller JM; Fiedel BA; Kinoshita CM; Gewurz H
    Inflammation; 1988 Aug; 12(4):391-405. PubMed ID: 2459061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of bovine platelet function by C-reactive protein.
    Cheryk LA; Hayes MA; Gentry PA
    Vet Immunol Immunopathol; 1996 Jun; 52(1-2):27-36. PubMed ID: 8807774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
    Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
    Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential roles of integrins alpha2beta1 and alphaIIbbeta3 in collagen and CRP-induced platelet activation.
    Jarvis GE; Best D; Watson SP
    Platelets; 2004 Aug; 15(5):303-13. PubMed ID: 15370101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of modified C-reactive protein in the modulation of platelet function under different experimental conditions.
    Boncler M; Rywaniak J; Sicinska P; Watala C
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):301-9. PubMed ID: 21372690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein.
    Zouki C; Beauchamp M; Baron C; Filep JG
    J Clin Invest; 1997 Aug; 100(3):522-9. PubMed ID: 9239398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of platelet activation by peptide analogs of the beta(3)-intracellular domain of platelet integrin alpha(IIb)beta(3) conjugated to the cell-penetrating peptide Tat(48-60).
    Dimitriou AA; Stathopoulos P; Mitsios JV; Sakarellos-Daitsiotis M; Goudevenos J; Tsikaris V; Tselepis AD
    Platelets; 2009 Dec; 20(8):539-47. PubMed ID: 19863457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic peptides from C-reactive protein containing tuftsin-related sequences.
    Buchta R; Fridkin M; Pontet M; Romeo D
    Peptides; 1986; 7(6):961-8. PubMed ID: 3031632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
    Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
    Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
    Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
    J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the effect of decorsin and two disintegrins, albolabrin and eristostatin, on platelet function.
    McLane MA; Gabbeta J; Rao AK; Beviglia L; Lazarus RA; Niewiarowski S
    Thromb Haemost; 1995 Nov; 74(5):1316-22. PubMed ID: 8607116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of platelet guanylyl cyclase by collagen: evidence that Glycoprotein VI mediates platelet nitric oxide synthesis in response to collagen.
    Riba R; Sharifi M; Farndale RW; Naseem KM
    Thromb Haemost; 2005 Aug; 94(2):395-403. PubMed ID: 16113831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone deacetylase inhibitors reduce glycoprotein VI expression and platelet responses to collagen related peptide.
    Bishton MJ; Gardiner EE; Harrison SJ; Prince HM; Johnstone RW
    Thromb Res; 2013 Jun; 131(6):514-20. PubMed ID: 23642854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptides derived from C-reactive protein inhibit neutrophil alveolitis.
    Heuertz RM; Ahmed N; Webster RO
    J Immunol; 1996 May; 156(9):3412-7. PubMed ID: 8617967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct roles of GPVI and integrin alpha(2)beta(1) in platelet shape change and aggregation induced by different collagens.
    Jarvis GE; Atkinson BT; Snell DC; Watson SP
    Br J Pharmacol; 2002 Sep; 137(1):107-17. PubMed ID: 12183336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stability of sterile saline solutions of synthetic tuftsin, a naturally occurring immunomodulating peptide.
    Nishioka K; Dessens SE; Rodriguez T
    Pept Res; 1991; 4(4):230-3. PubMed ID: 1823602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A hypothesis resolving the apparently disparate activities of native and altered forms of human C-reactive protein.
    Shields MJ
    Immunol Res; 1993; 12(1):37-47. PubMed ID: 8515183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic effects of a synthetic peptide of C-reactive protein in pre-clinical tumor models.
    Barna BP; Eppstein DA; Thomassen MJ; Nestor JJ; Ho T; Medendorp SV; Deodhar SD
    Cancer Immunol Immunother; 1993; 36(3):171-6. PubMed ID: 8439977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of tuftsin activity by the partial sequences of adenovirus type 2 proteins.
    Siemion IZ; Słoń JJ; Wieczorek Z
    Int J Pept Protein Res; 1993 Mar; 41(3):300-6. PubMed ID: 8463053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of C-reactive protein (CRP) on platelet function.
    Fiedel BA; Simpson RM; Gewurz H
    Ann N Y Acad Sci; 1982; 389():263-73. PubMed ID: 7046580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.